Continue Reading
Full article on Unknown
Moleculin Announces Reverse Stock Split
Market Intelligence Analysis
AI-Powered
Why This Matters
Moleculin Biotech announced a 1-for-25 reverse stock split, effective December 1, 2025, to increase the stock's trading value and potentially improve its market standing.
Market Impact
Market impact analysis based on neutral sentiment with 71% confidence.
Sentiment
Neutral
AI Confidence
71%
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to effect a 1-for-25 reverse stock split of its common stock. The reverse stock split will take effect at 12:01 am (Eastern Time) on December 1, 2025, and the Company’s common stock will open for trading on The Nasdaq Capital Market
Original article published by
Unknown
on November 26, 2025.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.